Year |
Title |
Other authors |
Journal and Publisher /
Conference |
Vol. |
Pages |
2023 |
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. |
Solomonidou N, Germanou D, Strouthos I, Karagiannis E, Farolfi A, Koerber SA, Debus J, Peeken JC, Vogel ME, Spohn SKB, Shelan M, Aebersold D, Grosu AL, Ceci F, Kroeze SGC, Guckenberger M, Fanti S, Belka C, Hruby G, Scharl S, Wiegel T, Bartenstein P, Henkenberens C, Emmett L, Schmidt-Hegemann NS, Ferentinos K, Zamboglou C |
Eur J Nucl Med Mol Imaging |
Ahead of print |
10.1007/s00259-023-06185-5 |
2023 |
Parathyroid imaging. |
Petranović Ovčariček P, Giovanella L |
Q J Nucl Med Mol Imaging |
Ahead of print |
10.23736/S1824-4785.23.03511-2 |
2023 |
Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review. |
Luisa Garo M, Deandreis D, Campennì A, Petranovic Ovcaricek P, Giovanella L. |
Endocr Connect. |
12 |
3959-3963 |
2022 |
SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management-the EANM perspective. |
Petranović Ovčariček P, Kreissl MC, Campenni A, de Keizer B, Tuncel M, Deandreis D, Giovanella L. |
Eur J Nucl Med Mol Imaging |
12 |
3959-3963 |
2022 |
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy. |
Zamboglou C, Strouthos I, Sahlmann J, Farolfi A, Serani F, Medici F, Cavallini L, Morganti AG, Trapp C, Koerber SA, Peeken JC, Vogel MME, Schiller K, Combs SE, Eiber M, Ferentinos K, Spohn SKB, Kirste S, Gratzke C, Ruf J, Grosu AL, Ceci F, Fendler WP, Miksch J, Kroeze S, Guckenberger M, Lanzafame H, Fanti S, Hruby G, Wiegel T, Emmett L, Schmidt-Hegemann NS, Henkenberens C |
Int J Radiat Oncol Biol Phys |
113 |
1015-1024 |
2022 |
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version |
Avram AM, Giovanella L, Greenspan B, Lawson SA, Luster M, Van Nostrand D, Peacock JG, Ovčariček PP, Silberstein E, Tulchinsky M, Verburg FA |
J Nucl Med |
49 |
3316-3319 |
2022 |
Editorial: Principles and Clinical Applications of Interstitial Brachytherapy. |
- |
Front Oncol |
5 |
1272 |
2020 |
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer. |
Iakovou I, Giannoula E, Giovanella L. |
Eur J Endocrinol |
1 |
41-48 |
2018 |
177Lu-DOTATATE Therapy in Radioiodine-refractory Differentiated Thyroid Cancer: A Single Center Experience. |
Roll W, Riemann B, Schäfers M, Stegger L |
Clin Nucl Med |
10 |
346-351 |
2017 |
Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients |
Gonzalez Carvalho JM, Görlich D, Schober O, Wenning C, Riemann B, Verburg FA |
Eur J Nucl Med Mol Imaging |
5 |
744-756 |